These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 33475081)

  • 1. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective.
    Kaur G; Agarwal R; Sharma RK
    Food Environ Virol; 2021 Dec; 13(4):433-446. PubMed ID: 34120319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
    Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
    Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage as an antibacterial agent: a patent perspective.
    Pathak-Vaidya P; Sharma S; Telang M
    Future Microbiol; 2021 Nov; 16():1327-1339. PubMed ID: 34755539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage Therapy as a Protective Tool Against Pathogenic Bacteria: How Far We Are?
    Singh K; Biswas A; Chakrabarti AK; Dutta S
    Curr Pharm Biotechnol; 2023; 24(10):1277-1290. PubMed ID: 36503459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple Two-step, High Yield Protocol for Isolation and Amplification of Bacteriophages Against Methicillin-resistant Staphylococcus Aureus (MRSA).
    Khan A; Joshi H
    Curr Protoc; 2022 Mar; 2(3):e395. PubMed ID: 35259286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
    Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy.
    Oechslin F
    Viruses; 2018 Jun; 10(7):. PubMed ID: 29966329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again.
    Squires RA
    N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the animal host in the management of bacteriophage resistance during phage therapy.
    Gaborieau B; Debarbieux L
    Curr Opin Virol; 2023 Feb; 58():101290. PubMed ID: 36512896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring bacteriophage therapy for drug-resistant bacterial infections.
    Schooley RT
    Top Antivir Med; 2023 Mar; 31(1):23-30. PubMed ID: 37018733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rekindling of a Masterful Precedent; Bacteriophage: Reappraisal and Future Pursuits.
    Abd-Allah IM; El-Housseiny GS; Yahia IS; Aboshanab KM; Hassouna NA
    Front Cell Infect Microbiol; 2021; 11():635597. PubMed ID: 34136415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host.
    Mikonranta L; Buckling A; Jalasvuori M; Raymond B
    Biol Lett; 2019 Mar; 15(3):20180895. PubMed ID: 30836884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.